Drug maker United Laboratories sells $125 million of CBs

United Labs' renminbi-denominated convertible bond comes at attractive terms, but still falls below par.

Drug maker United Laboratories sells $125 million of CBs

United Laboratories International, a Hong Kong-listed Chinese manufacturer of generic Western drugs, yesterday raised Rmb790 million $125 million from the sale of convertible bonds. Being the first Asian CB since Rexlot Holdings’ $105 million Hong Kong dollar-denominated deal on September 21 and only the second trade since early August, the deal attracted a lot of attention as market participants look for a possible reopening of the CB market.

True, Temasek Holdings issued S$650 million...

To continue reading, please login or register for free

Click for more on: convertible | pharmaceuticals | drugs | healthcare | hsbc

Print Edition

FinanceAsia Print Edition

CONFERENCES